Adaptive Biotechnologies (NASDAQ:ADPT) delivered strong financial results in its fourth quarter and full-year 2025 earnings presentation, highlighting substantial revenue growth and progress toward ...
Rahul Banerjee, MD, FACP, assistant professor in the Division of Hematology and Oncology, at the University of Washington, determines the optimal use of minimal residual disease (MRD) in individual ...
Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer in the United States Of 266 included patients, estimated relapse-free survival (RFS) and overall survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results